Not applicableStudy completedNCT05886478What this trial is testingA Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab VedotinWho this might be right forT-Cell Lymphoma Takeda 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724782What this trial is testingMulti-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCLWho this might be right forPTCL-NOS Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)UnknownNCT02134262What this trial is testingGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesWho this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Jichi Medical University 18
Not applicableWithdrawnNCT05106192What this trial is testingTriamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.Who this might be right forMycosis Fungoides of Skin (Diagnosis)Cutaneous T-cell LymphomaNon Hodgkin Lymphoma+3 more Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387What this trial is testingChidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Peking University Cancer Hospital & Institute 45
Not applicableStudy completedNCT00004875What this trial is testingHeparin or Enoxaparin in Patients With CancerWho this might be right forLymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific Northwestern University 6
Testing effectiveness (Phase 2)Study completedNCT00374699What this trial is testingBortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell LymphomasWho this might be right forPeripheral T-Cell LymphomasNon-Hodgkin Lymphoma Samsung Medical Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT07502768What this trial is testingTislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaWho this might be right forExtranodal NK/T-cell LymphomaNK/T-cell LymphomaRelapsed or Refractory NK/T-Cell Lymphoma Rong Tao 107
Testing effectiveness (Phase 2)Looking for participantsNCT05675813What this trial is testingGenotype-guided Treatment in Newly Diagnosed PTCLWho this might be right forPeripheral T Cell Lymphoma Ruijin Hospital 264
Not applicableEnded earlyNCT01663571What this trial is testingSTAT3 in T Cells: At The Crossroads of Inflammation and CancerWho this might be right forCutaneous T Cell Lymphoma NYU Langone Health 35
Not applicableLooking for participantsNCT02682667What this trial is testingBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsWho this might be right forMultiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more National Cancer Institute (NCI) 500
Very early researchUnknownNCT06277011What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma Anhui Provincial Hospital 18
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)Study completedNCT00051597What this trial is testingA Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesWho this might be right forHodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more Seagen Inc. 70
Early research (Phase 1)Ended earlyNCT03579888What this trial is testingCD19-Specific T Cells Post AlloSCTWho this might be right forB Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A RearrangedRecurrent B Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+14 more M.D. Anderson Cancer Center 4
Early research (Phase 1)Study completedNCT00554827What this trial is testingStudy of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaWho this might be right forCutaneous T-cell Lymphoma Acrotech Biopharma Inc. 55
Early research (Phase 1)Study completedNCT01689220What this trial is testingSP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaWho this might be right forPeripheral T-cell Lymphoma Solasia Pharma K.K. 6
Testing effectiveness (Phase 2)UnknownNCT04615468What this trial is testingTQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）Who this might be right forPeripheral T-cell Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25